(Q24187272)

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

An outbreak of rubella in British troops in Bosnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

PREVENTION OF RUBELLA BY GAMMA GLOBULIN DURING AN EPIDEMIC IN BARROW, ALASKA, IN 1964.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Nasal immunoglobulin responses in acute rubella determined by the immunofluorescent technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Specific immunoglobulins in infants with the congenital rubella syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Epidemiological and molecular assessment of a rubella outbreak in North‐Eastern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella outbreak in a prenatal clinic: management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Letter: Gammaglobulin and congenital rubella.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

21 January 2018

THE RUBELLA SYNDROME.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Prevention of rubella transmission in medical facilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Immunoglobulin responses in rubella and its complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella: the challenge of its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Immunoglobulins in infants of rubella-exposed mothers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Prophylaxis of German measles with immune serum globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

An outbreak of congenital rubella in Chicago

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

[Passive rubella prophylaxis. Influence of rubella-immune globulin on success rate of the immunization (author's transl)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Gammaglobulin in prevention of rubella and congenital defect: a study of 30,000 pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Congenital rubella syndrome in a child born to Liberian refugees: clinical and public health perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella epidemic, 1964: effect on 6,000 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

The use of gamma globulin from large pools of adult blood plasma in certain infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Trial of high-titre human rubella immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Modern plasma fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Antibodies, viruses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Modelling the incidence of congenital rubella syndrome in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella infection in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella epidemiology in Africa in the prevaccine era, 2002-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Antibodies against viruses: passive and active immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Toward rubella elimination in Europe: an epidemiological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

The routine serological investigation of cases and contacts of rubella

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Neutralization of animal virus infectivity by antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Antibodies for the prevention and treatment of viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

IVIG--mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Rubella revisited: where are we on the road to disease elimination in Central Europe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Humoral immune response after primary rubella virus infection and after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Gamma globulin prophylaxis; inactivated rubella virus; production and biologics control of live attenuated rubella virus vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

A NATURAL EPIDEMIC OF RUBELLA IN A CLOSED POPULATION: VIROLOGICAL AND EPIDEMIOLOGICAL OBSERVATIONS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

RUBELLA EPIDEMIC ON ST. PAUL ISLAND IN THE PRIBILOFS, 1963. I. EPIDEMIOLOGICAL, CLINICAL, AND SEROLOGICAL FINDINGS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

EXPERIMENTAL STUDIES WITH RUBELLA: EVALUATION OF GAMMA GLOBULIN FOR PORPHYLAXIS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

The British Standard for anti-rubella serum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Limited search strategies were effective in finding relevant nonrandomized studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Rubella seroprevalence in women in the reproductive period, Mersin, Turkey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Incidence of anomalous development following maternal rubella. Effect of clinical infection or exposure and treatment with gamma globulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

The rubella problem: clinical aspects, risk of fetal abnormality, and methods of prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Gamma globulin in pediatrics.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

The prophylactic value of gamma globulin in rubella

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Congenital rubella syndrome: a continuing conundrum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Rubella in a remote community

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Protection of pregnant women against rubella.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Vaccines to prevent rubella

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

[Effective employment of rubella-immunoglobulin (author's transl)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Effectiveness of intravenous gammaglobulin preparations: comparison between Sandoglobulin and gamma-Venin in the prevention of rubella infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Rubella: demonstration of neutralizing antibody in gamma globulin and re-evaluation of the rubella problem

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Epidemic rubella in Taiwan, 1957-1958. III. Gamma globulin in the prevention of rubella

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

The clinical use of gamma globulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Uses of hyperimmune human gamma globulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

An outbreak of rubella among hospital personnel

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Gamma globulin and rubella

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Protection of nonimmune volunteers against rubella by intravenous administration of normal human gamma globulin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Rubella outbreak, Fort Bragg, North Carolina, 1995: a clash of two preventive strategies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Gamma globulin against rubella in pregnancy. I. Prevention of maternal rubella by gamma globulin and convalescent gamma globulin: a follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Gamma globulin against rubella in pregnancy. II. Manifestmaternal rubella in early pregnancy treated with convalescent gamma globlin: a follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Rubella Epidemic in a Maternity Unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Clinical and Serological Assessment of Children Exposed in Utero to Confirmed Maternal Rubella

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Gamma-globulin for Prevention of Rubella in Pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Incidence of rubella antibodies among pregnant women in six areas: prophylactic effect of two doses of gammaglobulin. Report to the Public Health Laboratory Service Rubella Working Party

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Forgotten, but not gone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Rubella antibody levels in commercial gamma globulin preparations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Seroprevalence of rubella among urban and rural Bangladeshi women emphasises the need for rubella vaccination of pre-pubertal girls

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

Convalescent rubella gamma globulin as a possible prophylactic against rubella

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010586.PUB2

7 January 2021

10.1002/14651858.CD010586.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4498167

OpenCitations bibliographic resource ID

4498167

1 reference